University of New Hampshire, College of Health and Human Services, Institute on Disability, 10 West Edge Drive, Suite 101, Durham, NH, 03102, USA.
University of New Hampshire, College of Health and Human Services, Institute on Disability, 10 West Edge Drive, Suite 101, Durham, NH, 03102, USA.
Disabil Health J. 2019 Jul;12(3):519-522. doi: 10.1016/j.dhjo.2018.12.001. Epub 2018 Dec 15.
Prescription opioid use among people with disabilities has not been well characterized.
To examine prescription opioid use, misuse, and use disorder, reason and source for last prescription opioid misuse, and receipt of prescription opioid treatment among people with and without disabilities.
Stratified analysis of prescription opioid use, misuse, and use disorders; primary reason and primary source for last prescription opioid misuse; receipt of prescription opioid treatment; and disability status among civilian, noninstitutionalized adults (ages 18+) using data from the 2015-2016 National Survey on Drug Use and Health.
Adults with disabilities were significantly more likely than adults without disabilities to experience past year prescription opioid use (52.3% for those with disabilities compared to 32.8% of those without), misuse (4.4% compared to 3.4%), and use disorders (1.5% compared to 0.5%). People with disabilities were significantly more likely to misuse opioids for pain (Risk Ratio = 1.5, p < 0.001) and to receive opioids from a healthcare provider (Risk Ratio = 2.0, p < 0.001). Among people with opioid use disorder, people with disabilities were less likely to receive treatment for prescription opioid use (Risk Ratio = 0.6, p = 0.067).
In the U.S., a substantial population with disabilities using and misusing prescription opioids exists that has not been well characterized. Persons with disabilities experience disparities in reason and source for last opioid misuse. Healthcare and substance abuse prevention, intervention and treatment providers must collaborate to address the needs of this population.
残疾人群体中的处方阿片类药物使用情况尚未得到充分描述。
研究残疾人群体和非残疾人群体中，处方阿片类药物的使用、滥用和用药障碍情况，上次处方阿片类药物滥用的原因和来源，以及接受处方阿片类药物治疗的情况。
利用 2015-2016 年全国毒品使用与健康调查的数据，对处方阿片类药物使用、滥用和用药障碍情况；上次处方阿片类药物滥用的主要原因和主要来源；接受处方阿片类药物治疗的情况；以及残疾状况进行分层分析。研究对象为年龄在 18 岁及以上的平民、非住院成年人。
与非残疾成年人相比，残疾成年人过去一年中使用处方阿片类药物（残疾者为 52.3%，而非残疾者为 32.8%）、滥用（残疾者为 4.4%，而非残疾者为 3.4%）和用药障碍（残疾者为 1.5%，而非残疾者为 0.5%）的可能性显著更高。残疾者更有可能因疼痛而滥用阿片类药物（风险比=1.5，p<0.001），也更有可能从医疗保健提供者那里获得阿片类药物（风险比=2.0，p<0.001）。在患有用药障碍的人群中，残疾者接受处方阿片类药物治疗的可能性显著更低（风险比=0.6，p=0.067）。
在美国，存在着大量未被充分描述的残疾人群体在使用和滥用处方阿片类药物。残疾者在最后一次阿片类药物滥用的原因和来源方面存在差异。医疗保健和药物滥用预防、干预和治疗提供者必须合作，以满足这一人群的需求。
